In the analyses we compared the use of GLP-1 RAs and use of SGLT-2 inhibitors or DPP-4 inhibitors, respectively
These health concerns have raised serious questions about the drugs safety, and now, Ozempic lawsuits filed across the country claim that drug manufacturers failed to adequately warn users of these health risks
The MHRA said that between 2007 and October 2025 it received 1,296 Yellow Card reports of pancreatitis associated with these medicines, including 19 that involved a patient fatality and 24 reports of necrotising pancreatitis
GLP-1s are biologics, complex drugs that are expensive to manufacture and still under patent protection
A 24-week Phase II trial was conducted at five obesity centers in Denmark to assess the efficacy and safety of TE in treating obesity
Bryophyllum pinnatum Induces p53-dependent apoptosis of colorectal cancer cells via increased intracellular ROS and G2/M cell-cycle arrest in vitro and validated in silico by molecular docking